StonvexLoading…
StonvexStonvexStonvexCore line items from DBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-11-02 | Annual 2024 2024-08-03 |
|---|---|---|---|---|
Revenue | $2.89B | $3.01B | $777.19M | $771.90M |
Operating Income | $47.76M | $34.93M | $22.82M | $28.59M |
Net Income | $-8.37M | $-10.55M | $13.01M | $13.82M |
EPS (Diluted) | $-0.17 | $-0.20 | $240.00 | $240.00 |
Total Assets | $1.95B | $2.01B | Not available | Not available |
Total Liabilities | $1.66B | $1.73B | Not available | Not available |
Cash & Equivalents | $50.87M | $44.75M | Not available | Not available |
Free Cash Flow OCF − CapEx | $78.25M | $31.34M | Not available | Not available |
Shares Outstanding | 49.14M | 53.66M | Not available | Not available |